Results 141 to 150 of about 37,793 (186)

Time-varying characteristics of remdesivir-treated patients hospitalised due to COVID-19: an electronic health record study. [PDF]

J Glob Health
Hoe JK, Blond K, Jimenez-Solem E, Berry M, Chiang M, Ankarfeldt MZ, Petersen J.   +6 more
europepmc   +1 more source

Repurposing FDA-Approved Drugs as Potential Inhibitors of Feline Infectious Peritonitis Virus 3CL^pro: An Integrated In Silico and In Vitro Study with Synergistic Combination Analysis. [PDF]

ACS Pharmacol Transl Sci
Lueangaramkul V, Mana N, Thangthamniyom N, Semkum P, Lekcharoensuk P, Limprasutr V, Theerawatanasirikul S.   +6 more
europepmc   +1 more source

Electrocardiographic Profile of Adult Patients with Coronavirus Disease (COVID-19) who were Given Remdesivir and Admitted in the University of the Philippines-Philippine General Hospital (UP-PGH). [PDF]

Acta Med Philipp
Lustestica KEL, Punzalan FER, Alad PAO, Aya-Ay TAP, Nelson ZOM, Ramirez BPG, Santos NJC, Llanes EJB.   +7 more
europepmc   +1 more source

Efficacy and safety of remdesivir for patients with severe acute respiratory syndrome coronavirus 2 infection: A systematic review of randomized controlled trials.

Indian J Pharmacol
Meena J, Agarwal A, Sandhu A, Pradhan P, Singh M.   +4 more
europepmc   +1 more source

Correction: Exploring the clinical effects of <i>Andrographis paniculata</i>-derived compounds, its extract, or derivatives for the treatment of COVID-19: a systematic review and meta-analysis. [PDF]

Front Pharmacol
Prabhakornritta P, Waranuch N, Fuangchan A, Srikham K, Boonpattharatthiti K, Barnig C, Boonyasuppayakorn S, Pitaksuteepong T, Bhattarakosol P, Moulari B, Pellequer Y, Dhippayom T.   +11 more
europepmc   +1 more source

Safety and efficacy of major antiviral and immune therapies in pregnancy for maternal viral infections: evidence synthesis of maternal and neonatal outcomes. [PDF]

Front Med (Lausanne)
Sleman S, Abid OI, Abdullah BJ, Abass ZA, Ameen MB.   +4 more
europepmc   +1 more source

Bayesian reanalysis of early remdesivir for the treatment of COVID-19 in outpatients with high risk of progression to severe disease. [PDF]

PLoS One
Abdelghany M, Yu F, Rennard S, Gwon Y.
europepmc   +1 more source

Small Molecule Inhibition of Mononegavirales RNA Polymerases. [PDF]

J Med Virol
Cao CR, Mohammed M, Yang G, Wang D.
europepmc   +1 more source

Impact of Early COVID-19 Antiviral Therapy on the Incidence of Uveitis: A Retrospective Cohort Study Using the TriNetX Database. [PDF]

Immun Inflamm Dis
Kuo HT, Hsu AY, Liu DY, Wu BQ, Wei JC, Hsia NY, Shao YC, Lai CT, Chiang CC, Lin CJ, Chen HS, Wang YH, Tseng H, Hsu HC, Tsai YY.   +14 more
europepmc   +1 more source

Evaluation of artificial intelligence identified ipratropium bromide for the treatment of coronavirus disease 2019. [PDF]

Sci Rep
Jung DS, Cheon S, Kim CM, Seo JW, Sung SJ, Kim DY, Lee JH, Kim W, Kang J, Yun NR, Kim YR, Kim DM.   +11 more
europepmc   +1 more source